OCIAD1-AS1

Across TCGA pan-cancer cohorts, OCIAD1-AS1 RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of OCIAD1-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney chromophobe (KICH), where OCIAD1-AS1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OCIAD1-AS1 is over-expressed in tumor, although a few such as PAAD and UCEC show the opposite, repressed pattern.

KICH, KIRC, and CHOL are the cancer types where OCIAD1-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OCIAD1-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KICH	All	All	+0.490	<.001	6	view →
KIRC	All	All	+0.239	.002	4	view →
CHOL	All	All	+1.392	<.001	3	view →
PAAD	Female	All	−0.534	.005	2	view →
STAD	All	II,III,IV	+0.497	.023	2	view →
UCEC	All	All	−0.495	.022	2	view →
HNSC	All	All	+0.216	.023	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

OCIAD1-AS1–KICH

Open the KICH breakdown →